Omeros (OMER) Times Interest Earned (2010 - 2026)
Omeros (OMER) posted Times Interest Earned of -$2.96 for Q1 2026, up 30.6% sequentially from -$4.26 in Q4 2025, and up 13.63% YoY from -$2.6 in Q1 2025.
Omeros (OMER) Times Interest Earned (2010 - 2026) Analysis & Trends
Omeros has reported Times Interest Earned for 17 years, with the latest figure at -$2.96 in Q1 2026.
- Quarterly Times Interest Earned rose 13.63% year-over-year to -$2.96 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.39 (up 22.64% YoY) and the FY2025 annual result came in at -$0.67, up 77.51% from the prior year.
- Times Interest Earned improved to -$2.96 in Q1 2026 per OMER's latest filing, from -$4.26 in the prior quarter.
- Over five years, Times Interest Earned peaked at $3.81 in Q4 2022 and troughed at -$32.89 in Q4 2024.
- A 5-year average of -$5.98 and a median of -$4.74 in 2024 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2022 and 2024: Times Interest Earned soared 257.53% in 2022, then slumped 1718.48% in 2024.
- Over 5 years, Times Interest Earned stood at $3.81 in 2022, then sank by 147.49% to -$1.81 in 2023, then plunged by 1718.48% to -$32.89 in 2024, then surged by 87.05% to -$4.26 in 2025, then soared by 30.6% to -$2.96 in 2026.
- According to Business Quant data, Times Interest Earned over the past three periods registered -$2.96, -$4.26, and -$1.22 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | Omeros | 1.24 Bn | 1.24 Bn | 27.73 Mn | 0.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.00 |
| Mar 31, 2026 | -2.96 |
| Dec 31, 2025 | -4.26 |
| Sep 30, 2025 | -1.22 |
| Jun 30, 2025 | -2.51 |
| Mar 31, 2025 | -3.42 |
| Dec 31, 2024 | -32.89 |
| Sep 30, 2024 | -5.74 |
| Jun 30, 2024 | -6.42 |
| Mar 31, 2024 | -4.74 |
| Dec 31, 2023 | -1.81 |
| Sep 30, 2023 | -6.08 |
| Jun 30, 2023 | -5.16 |
| Mar 31, 2023 | -4.50 |
| Dec 31, 2022 | 3.81 |
| Sep 30, 2022 | -10.29 |
| Jun 30, 2022 | -7.60 |
| Mar 31, 2022 | -5.87 |
| Dec 31, 2021 | -2.42 |
| Sep 30, 2021 | -1.73 |